Aztreonam-avibactam for the treatment of intra-abdominal infections

Hannah Delp1, Gabrielle A Gibson1, Sara A Buckman2

  • 1Pharmacy Department, Barnes-Jewish Hospital Plaza, St Louis, MO, USA.

PubMed
Abstract

Insights

Aztreonam/avibactam (ATM-AVI) offers a new treatment for complicated intra-abdominal infections. This combination antibiotic effectively combats resistant gram-negative organisms, addressing a critical unmet need in patient care.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Microbiology

Background:

  • Intra-abdominal infections (IAIs) are increasingly prevalent, associated with significant morbidity and mortality.
  • Rising incidence of IAIs caused by antibiotic-resistant gram-negative organisms poses a therapeutic challenge.
  • Limited treatment options exist for IAIs caused by resistant gram-negative pathogens, particularly those with metallo-β-lactamases.

Purpose of the Study:

  • To evaluate aztreonam/avibactam (ATM-AVI) as a novel therapeutic option for complicated intra-abdominal infections.
  • To review the chemistry, pharmacodynamics, pharmacokinetics, and clinical data of ATM-AVI.
  • To discuss the role of ATM-AVI in managing infections caused by resistant gram-negative bacteria.

Main Methods:

  • Drug evaluation manuscript synthesizing existing data.
  • Review of antimicrobial agents for IAIs.
  • Analysis of clinical studies on ATM-AVI.

Main Results:

  • Aztreonam/avibactam (ATM-AVI) is a combination of aztreonam and avibactam, a broad-spectrum β-lactamase inhibitor.
  • ATM-AVI, in combination with metronidazole, is approved in Europe for complicated IAIs.
  • Demonstrated safety and efficacy for empiric treatment and targeted therapy against resistant gram-negative organisms.

Conclusions:

  • ATM-AVI represents a valuable addition to the therapeutic armamentarium against complicated IAIs.
  • It provides a crucial option for infections involving difficult-to-treat resistant gram-negative bacteria.
  • Recommended for empiric use in high-incidence areas and for culture-confirmed resistant infections.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
2
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
2
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
308
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
2
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
3
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
2